Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer. Academic Article uri icon

Overview

abstract

  • PURPOSE: We evaluated rapid androgen cycling in combination with docetaxel for men with progressive noncastrate prostate cancers. PATIENTS AND METHODS: Noncastrate patients with 150 ng/dL) and an undetectable prostate-specific antigen (PSA;

publication date

  • June 20, 2008

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Prostatic Neoplasms
  • Testosterone

Identity

PubMed Central ID

  • PMC3051836

Scopus Document Identifier

  • 46449127799

Digital Object Identifier (DOI)

  • 10.1200/JCO.2007.15.1928

PubMed ID

  • 18565882

Additional Document Info

volume

  • 26

issue

  • 18